Cancer Biotherapy and Radiopharmaceuticals
- h-index: 75
- Total citations: 41,809
- Total papers: 2,271
- Impact factor: 1.6904761904761905
Homepage: http://www.liebertpub.com/overview/cancer-biotherapy-and-radiopharmaceuticals/8
Homepage: http://www.liebertpub.com/overview/cancer-biotherapy-and-radiopharmaceuticals/8
Cancer Biotherapy and Radiopharmaceuticals carries 2,271 indexed papers, 41,809 citations, h-index 75 in Synapse's enriched corpus. Each paper indexed here includes structured clinical evidence extraction (PICO), methodology classification with level of evidence, and links to related guideline recommendations where applicable.
On Synapse's credibility score (derived from SJR ranking and cross-citation patterns), Cancer Biotherapy and Radiopharmaceuticals sits among the highest-credibility cardiovascular journals.
The journal's official homepage is at http://www.liebertpub.com/overview/cancer-biotherapy-and-radiopharmaceuticals/8.
Use the feed below to follow new Cancer Biotherapy and Radiopharmaceuticals publications with AI-enriched analysis — each paper is decomposed into study design, population, intervention, comparator, primary outcome, and key finding, with the underlying evidence traceable to the primary source.
Deterministic synthesis from Synapse's enriched records — 108 words.